Abingdon Health (LON:ABDX) Stock Price Up 2.5% – What’s Next?

Abingdon Health Plc (LON:ABDX)’s stock price was up 2.5% during mid-day trading on Thursday . The stock traded as high as GBX 6.50 and last traded at GBX 6.15. Approximately 511,024 shares traded hands during mid-day trading, an increase of 217% from the average daily volume of 161,005 shares. The stock had previously closed at GBX 6.

Abingdon Health Stock Up 2.5%

The firm has a 50-day moving average of GBX 6.41 and a two-hundred day moving average of GBX 6.33. The firm has a market cap of £15.44 million, a price-to-earnings ratio of -6.61 and a beta of 0.13. The company has a current ratio of 1.95, a quick ratio of 1.96 and a debt-to-equity ratio of 46.64.

Abingdon Health (LON:ABDX) last issued its quarterly earnings results on Tuesday, November 11th. The company reported GBX (0.71) EPS for the quarter. Abingdon Health had a negative return on equity of 62.56% and a negative net margin of 20.72%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.